Drug Type Interleukins |
Synonyms IL-3 (Immunex) |
Target |
Mechanism IL-3R agonists(Interleukin 3 receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Interleukin-3(Amgen, Inc.) | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia | Phase 2 | - | - | |
Anemia | Phase 2 | - | - | |
Bone Marrow Neoplasms | Phase 2 | - | - | |
Bone Marrow Neoplasms | Phase 2 | - | - |
Not Applicable | - | RGCs exposed to P2X7R agonist BzATP | vjsgmnanfn(tkhnxvxkmd) = vstdxzdcvv jqhvukomwk (rakilpktiu ) | - | 01 Mar 2012 |